RBQM Updates for Clinical Experts

Sep 2023

Pipeline Intelligence & M&A in the Modern Pharma Landscape

By |2023-09-05T14:37:50+02:00September 5, 2023|Blog, News|Comments Off on Pipeline Intelligence & M&A in the Modern Pharma Landscape

In a fast-changing pharma landscape, our MyRBQM® Portal transforms clinical trial and pipeline oversight and aids in M&A due diligence, offering a strategic edge in compliance and growth.

Jul 2023

Enhancing Clinical Trial Risk Management: A Response to the Growing Concerns over Fraudulent Studies

By |2023-07-20T12:20:47+02:00July 19, 2023|Blog, News|0 Comments

In this blog, we explore the growing concerns about fraudulent RCTs highlighted in a recent Nature article. Discover how innovative risk management approaches can detect, prevent, and tackle these issues, facilitating more robust regulatory oversight.

Jun 2023

Empowering Clinical Trials: MyRBQM Portal Debuts on Microsoft Azure Marketplace

By |2023-06-27T10:53:08+02:00June 27, 2023|News|0 Comments

MyRBQM Portal has made its debut on the Azure Marketplace. This milestone allows biopharmaceutical companies to streamline and unify their approach to risk management by using the secure and reliable Azure cloud platform.

Jun 2023

Boosting Oncology Care with Decentralized Clinical Trials

By |2023-06-06T15:11:23+02:00June 4, 2023|Blog, News|0 Comments

Discover how Decentralized Clinical Trials (DCTs) have the potential to reshape oncology care. Using our eyesON DCT Outlook, we reveal how patient demographics, broadband internet, and registered oncologists could drive DCT opportunities and potentially enhance cancer survivorship.

May 2023

eyesON | Decentralized Clinical Trials Outlook: USA

By |2023-06-21T17:28:49+02:00May 29, 2023|Interactive Data Visualizations, News|Comments Off on eyesON | Decentralized Clinical Trials Outlook: USA

Data visualization tool designed to identify untapped opportunities for Decentralized Clinical Trials advancement in the oncology sector in the USA.

Go to Top